World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
110
Citations
61584
World Ranking
487
National Ranking
295

Medicine

D-Index
110
Citations
61668
World Ranking
5442
National Ranking
2931

Overview

Bjoern Peters is affiliated with the La Jolla Institute For Allergy & Immunology in the United States. Their research primarily spans the fields of Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Within these fields, the scientist has focused on subfields such as Molecular Biology, Immunology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging, and Oncology.

The research topics frequently addressed include vaccines and immunoinformatics approaches, immunotherapy and immune responses, monoclonal and polyclonal antibodies research, SARS-CoV-2 and COVID-19 research, T-cell and B-cell immunology, tuberculosis research and epidemiology, and COVID-19 clinical research studies.

Bjoern Peters has co-authored publications with several frequent collaborators, including:

  • Alessandro Sette (124 joint publications)
  • Jason Greenbaum (44 joint publications)
  • Cecilia S. Lindestam Arlehamn (42 joint publications)
  • April Frazier (31 joint publications)
  • Morten Nielsen (31 joint publications)

Their scholarly output has appeared in notable publication venues, with multiple contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory) - 38 publications
  • The Journal of Immunology - 22 publications
  • JCI Insight - 9 publications
  • Database - 7 publications
  • Frontiers in Immunology - 7 publications

Key recent papers authored or co-authored by Bjoern Peters include:

  • Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals, 2020, Cell
  • Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection, 2021, Science
  • NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data, 2020, Nucleic Acids Research
  • Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity, 2020, Cell
  • Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans, 2020, Science

Best Publications

  • Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.

    Alba Grifoni;Daniela Weiskopf;Sydney I. Ramirez;Sydney I. Ramirez;Jose Mateus

  • Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

    Jennifer M. Dan;Jennifer M. Dan;Jose Mateus;Yu Kato;Kathryn M. Hastie

  • The Immune Epitope Database (IEDB): 2018 update.

    Randi Vita;Swapnil Mahajan;James A Overton;Sandeep Kumar Dhanda

  • NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data.

    Birkir Reynisson;Bruno Alvarez;Sinu Paul;Bjoern Peters;Bjoern Peters

  • Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.

    Carolyn Rydyznski Moderbacher;Sydney I. Ramirez;Sydney I. Ramirez;Jennifer M. Dan;Jennifer M. Dan;Alba Grifoni

  • BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes

    Martin Closter Jespersen;Bjoern Peters;Morten Nielsen;Paolo Marcatili

  • NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data

    Vanessa Isabell Jurtz;Sinu Paul;Massimo Andreatta;Paolo Marcatili

  • The immune epitope database (IEDB) 3.0

    Randi Vita;James A. Overton;Jason A. Greenbaum;Julia V. Ponomarenko

  • Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.

    Jose Mateus;Alba Grifoni;Alison Tarke;John Sidney

  • A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2

    Alba Grifoni;John Sidney;Yun Zhang;Richard H. Scheuermann

  • A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach

    Peng Wang;John Sidney;Courtney Dow;Courtney Dow;Bianca Mothé

  • Properties of MHC Class I Presented Peptides That Enhance Immunogenicity

    Jorg J. A. Calis;Matt Maybeno;Jason A. Greenbaum;Daniela Weiskopf

  • NetMHCpan, a method for MHC class I binding prediction beyond humans

    Ilka Hoof;Bjoern Peters;John Sidney;Lasse Eggers Pedersen

  • T cells from patients with Parkinson’s disease recognize α-synuclein peptides

    David Sulzer;Roy N. Alcalay;Francesca Garretti;Lucien Cote

  • Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression.

    Benjamin J. Schmiedel;Divya Singh;Ariel Madrigal;Alan G. Valdovino-Gonzalez

  • HLA class I supertypes: a revised and updated classification

    John Sidney;Bjoern Peters;Nicole Frahm;Christian Brander

  • Improved methods for predicting peptide binding affinity to MHC class II molecules

    Kamilla Kjærgaard Jensen;Massimo Andreatta;Paolo Marcatili;Søren Buus

  • NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence.

    Morten A. Nielsen;Claus Lundegaard;Thomas H. Blicher;Kasper Lamberth

  • The Immune Epitope Database 2.0

    Randi Vita;Laura Zarebski;Jason A. Greenbaum;Hussein Emami

  • Peptide binding predictions for HLA DR, DP and DQ molecules

    Peng Wang;John Sidney;Yohan Kim;Alessandro Sette

Frequent Co-Authors

Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology
John Sidney
John Sidney La Jolla Institute For Allergy & Immunology
Jason A. Greenbaum
Jason A. Greenbaum La Jolla Institute For Allergy & Immunology
Daniela Weiskopf
Daniela Weiskopf La Jolla Institute For Allergy & Immunology
Pandurangan Vijayanand
Pandurangan Vijayanand La Jolla Institute For Allergy & Immunology
Carla Oseroff
Carla Oseroff La Jolla Institute For Allergy & Immunology
Morten Nielsen
Morten Nielsen Technical University of Denmark
Simon Mallal
Simon Mallal Vanderbilt University Medical Center
Shane Crotty
Shane Crotty La Jolla Institute For Allergy & Immunology
Howard M. Grey
Howard M. Grey La Jolla Institute For Allergy & Immunology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students choose to pursue nursing programs, which often complement a background in immunological sciences. Programs with easier admission processes provide accessible pathways to build clinical experience and advance professionally.

If you’re considering a nursing career, checking out the easiest accelerated nursing programs to get into can help you identify options that balance quality education with more flexible entry requirements.

For a quicker path into nursing, easy admission LPN programs offer foundational training that prepares students for practical roles in healthcare settings. These programs often serve as stepping stones toward advanced degrees in nursing or healthcare.

Those aiming for advanced practice roles might explore the easiest NP programs to get into, which combine specialized clinical training with flexible online learning options. Additionally, online PMHNP programs with clinical placement provide excellent support for mental health nurse practitioners, ensuring strong practical experience through effective clinical placements.

Choosing the right program involves balancing admission criteria, program format, and clinical opportunities to align with your career goals in the evolving field of immunology and healthcare.

Best Scientists Citing Bjoern Peters

Trending Scientists